foxo4-dri senolytic peptide human trial 2024 2025

foxo4-dri senolytic peptide human trial 2024 2025 Frontiers FOXO4-DRI alleviates age-related testosterone secretion

Name: foxo4-dri senolytic peptide human trial 2024 2025 Frontiers FOXO4-DRI alleviates age-related testosterone secretion
Brand: usmivani.cz
SKU: 22649976087
Price: 27.16 USD
Availability: InStock
Rating: 4.4284 (30 reviews)

FOXO4 DRI alleviates age related testosterone secretion insufficiency by targeting senescent Leydig cells in aged mice Aging Heterogeneity of Cellular Senescence, Senotyping, and Targeting by Senolytics and Senomorphics in Lung Diseases[v1] Peptide inhibitors targeting FOXO4 p53 interactions and inducing senescent cancer cell specific apoptosis bioRxiv Senolytics: charting a new course or enhancing existing anti tumor therapies? Cellular Oncology Springer Nature Link

SKU: 22649976087 · From usmivani.cz

4.4

USD27.16 USD71.16

Pay in 4 interest-free payments of $6.79 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 4 - Aug 9

Description

Decreased blood counts Decreases in blood cell count can be caused by multiple myeloma itself and also by many myeloma therapies

Book online today

The main structural parameters assessed included LV diastolic diameter, LV systolic diameter, interventricular septal thickness during systole, and LV posterior wall thickness during systole